Con­tra­cep­tive mak­er Evofem lets com­mer­cial chief go, cuts CEO pay 40% to save cash

A month af­ter say­ing it would look for “strate­gic al­ter­na­tives,” con­tra­cep­tive mak­er Evofem Bio­sciences’ board has ap­proved lay­offs and a 40% cut to the CEO …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER